Solifenacin Flexible Dosing Study in Frequent Micturition Patients With and Without Urgency
NCT00979472 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 291
Last updated 2016-02-02
Summary
The purpose of the study is to compare the effect of solifenacin succinate between frequent micturition patients with urgency and those without urgency.
Conditions
- Urinary Bladder, Overactive
- Overactive Bladder
Interventions
- DRUG
-
Solifenacin
oral
Sponsors & Collaborators
-
Astellas Pharma Korea, Inc.
collaborator INDUSTRY -
Asan Medical Center
lead OTHER
Principal Investigators
-
Myung-Soo Choo, Professor · Asan Medical Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-04-30
- Primary Completion
- 2010-06-30
- Completion
- 2010-06-30
Countries
- South Korea
Study Locations
More Related Trials
-
A Study Comparing the Efficacy of an Alpha Blocker Versus an Alpha Blocker Plus Solifenacin in Men With Overactive Bladder
NCT00699049 ·Status: COMPLETED ·Phase: PHASE4
-
Solifenacin Succinate Versus Tolterodine 4mg Once Daily
NCT00802373 ·Status: COMPLETED ·Phase: PHASE3
-
A Therapeutic Exploratory Clinical Study of DA-8010 in Patients With Overactive Bladder
NCT03566134 ·Status: COMPLETED ·Phase: PHASE2
-
The Efficacy of Solifenacin With or Without Tamsulosin in Adult Women With Overactive Bladder (OAB)
NCT01533597 ·Status: COMPLETED ·Phase: PHASE4
-
Observational Study to Estimate the Dry Mouth in OAB Patients With Solifenacin
NCT01437670 ·Status: COMPLETED
-
Study of 2 Doses of Solifenacin Succinate in Female Subjects With Overactive Bladder.
NCT01093534 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy & Safety Study of VESIcare® (Solifenacin Succinate) in Patients Wishing to Switch From Detrol LA® for Treatment of Overactive Bladder
NCT00454740 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Solifenacin With Bladder Training Versus Solifenacin Alone in Patients With Overactive Bladder (SOLAR)
NCT00337558 ·Status: COMPLETED ·Phase: PHASE4
-
A Registry Study of Patients Initiating a Course of Drug Therapy for Overactive Bladder in Taiwan, Korea and China
NCT03572231 ·Status: COMPLETED
-
A Double-Blind, Paralleled Study Comparing Efficacy/Safety of Solifenacin to Tolterodine in Overactive Bladder Patients
NCT00368706 ·Status: COMPLETED ·Phase: PHASE3
-
A Multicenter VESIcare® Efficacy and Safety Study for the Treatment of Urgency Associated With Overactive Bladder (OAB)
NCT00454896 ·Status: COMPLETED ·Phase: PHASE3
-
Solifenacin Succinate Versus Placebo in Inner City Women Ages 20-45 With Overactive Bladder
NCT00773552 ·Status: WITHDRAWN ·Phase: PHASE4
-
Reproducibility Study of OABSS and Its Response to Treatment
NCT02667470 ·Status: COMPLETED ·Phase: PHASE4
-
Single Dose Study to Measure Blood Levels and Safety of a Drug for Children With Overactive Bladder
NCT01539707 ·Status: COMPLETED ·Phase: PHASE1
-
Study of VESIcare® In Overactive Bladder (OAB) Subjects to Evaluate Symptom Bother and Health Related Quality of Life
NCT00573508 ·Status: COMPLETED ·Phase: PHASE4
-
A Multinational Study Comparing the Long-term Efficacy and Safety of Two Medicines, Solifenacin Succinate and Mirabegron Taken Together, or Separately, in Subjects With Symptoms of Overactive Bladder
NCT02045862 ·Status: COMPLETED ·Phase: PHASE3
-
This Was a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder
NCT01972841 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of DA-8010 in Patients With Overactive Bladder
NCT05282069 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Response of Overactive Bladder Symptom Score (OABSS) to Treatment
NCT01122563 ·Status: COMPLETED
-
Validation of a Real-time Urodynamic Measure of Urinary Urgency
NCT00909428 ·Status: COMPLETED ·Phase: PHASE4
-
Therapy of the Overactive Bladder Syndrome
NCT01314781 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate Solifenacin Succinate in Combination With Tamsulosin for the Treatment of Residual Overactive Bladder Symptoms (OAB) in Men.
NCT00333112 ·Status: COMPLETED ·Phase: PHASE4
-
Solifenacin Succinate Versus Fesoterodine A Comparison Trial for Urgency Symptoms
NCT01595152 ·Status: UNKNOWN ·Phase: NA
-
Single-dose Study to Assess Pharmacokinetics of Solifenacin Succinate Suspension in Children and Adolescents
NCT01262391 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Efficacy, Safety and Tolerability of Mirabegron and Solifenacin Succinate Alone and in Combination for the Treatment of Overactive Bladder
NCT01340027 ·Status: COMPLETED ·Phase: PHASE2